0001209191-21-064441.txt : 20211115 0001209191-21-064441.hdr.sgml : 20211115 20211115160319 ACCESSION NUMBER: 0001209191-21-064441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211111 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sacks Natalie CENTRAL INDEX KEY: 0001683811 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38800 FILM NUMBER: 211410197 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc. CENTRAL INDEX KEY: 0001708493 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473458693 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-443-7400 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-11 0 0001708493 Harpoon Therapeutics, Inc. HARP 0001683811 Sacks Natalie C/O HARPOON THERAPEUTICS, INC. 131 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer Employee Stock Option (right to buy) 7.73 2021-11-11 4 A 0 155000 0.00 A 2031-11-11 Common Stock 155000 155000 D Fifty percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 11, 2022, and thereafter twenty-five percent of the stock option shall vest on each May 11, 2023, and November 11, 2023. /s/ Natalie Sacks by Georgia Erbez, Attorney-in-Fact 2021-11-15